Literature DB >> 16733848

Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.

Xiao-Ping Chen1, Qi Wang, Jian Guan, Zhi-Yong Huang, Wan-Guang Zhang, Bi-Xiang Zhang.   

Abstract

AIM: To reverse the multidrug resistance (MDR) by RNA interference (RNAi)-mediated MDR1 suppression in hepatoma cells.
METHODS: For reversing MDR by RNAi technology, two different short hairpin RNAs (shRNAs) were designed and constructed into pGenSil-1 plasmid, respectively. They were then transfected into a highly adriamycin-resistant HepG2 hepatoma cell line (HepG2/ADM). The RNAi effect on MDR was evaluated by real-time PCR, cell cytotoxicity assay and rhodamine 123 (Rh123) efflux assy.
RESULTS: The stably-transfected clones showed various degrees of reversal of MDR phenotype. Surprisingly, the MDR phenotype was completely reversed in two transfected clones.
CONCLUSION: MDR can be reversed by the shRNA-mediated MDRI suppression in HepG2/ADM cells, which provides a valuable clue to make multidrug-resistant hepatoma cells sensitive to anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733848      PMCID: PMC4087887          DOI: 10.3748/wjg.v12.i21.3332

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  Time for voices to be raised.

Authors:  D Burke
Journal:  Nature       Date:  2000-06-01       Impact factor: 49.962

3.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

Review 4.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 5.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

6.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.

Authors:  T W Synold; I Dussault; B M Forman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

8.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

9.  Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.

Authors:  S Jin; B Gorfajn; G Faircloth; K W Scotto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

10.  Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.

Authors:  E Marthinet; G Divita; J Bernaud; D Rigal; L G Baggetto
Journal:  Gene Ther       Date:  2000-07       Impact factor: 5.250

View more
  6 in total

1.  Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells.

Authors:  Yan Yang; Zehua Wang; Minfang Li; Shi Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

2.  Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.

Authors:  Yi-Sheng Huang; Zhi Xue; Hua Zhang
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

3.  Role of Caveolin-1 in Indomethacin-induced Death of Human Hepatoadenocarcinoma SK-Hep1 Cells.

Authors:  Kyung-Nam Kim; Ju-Hee Kang; Sung-Vin Yim; Chang-Shin Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

4.  ROS-mediated enhanced transcription of CYP38 promotes the plant tolerance to high light stress by suppressing GTPase activation of PsbO2.

Authors:  Yongqiang Wang; Lizhang Zeng; Da Xing
Journal:  Front Plant Sci       Date:  2015-09-29       Impact factor: 5.753

5.  Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance.

Authors:  Stacey L Hembruff; Monique L Laberge; David J Villeneuve; Baoqing Guo; Zachary Veitch; Melanie Cecchetto; Amadeo M Parissenti
Journal:  BMC Cancer       Date:  2008-11-03       Impact factor: 4.430

Review 6.  Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system.

Authors:  Maria João Gomes; José das Neves; Bruno Sarmento
Journal:  Int J Nanomedicine       Date:  2014-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.